InnovAge Holding Corp. (NASDAQ:INNV) Q1 2025 Results Earnings Conference Call November 5, 2024 5:00 PM ET

Company Participants

Ryan Kubota - Director of Investor Relations
Patrick Blair - President and Chief Executive Officer
Benjamin Adams - Chief Financial Officer
Richard Feifer - Chief Medical Officer

Conference Call Participants

Jamie Perse - Goldman Sachs
Jared Haase - William Blair
Matt Gilmore - KeyBanc Capital Markets

Operator

Good day and thank you for standing by. Welcome to the InnovAge First Quarter 2025 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Ryan Kubota, Director of Investor Relations. Please go ahead.

Ryan Kubota

Thank you, operator. Good afternoon and thank you all for joining the InnovAge 2024 Fiscal First Quarter Earnings Call. With me today is Patrick Blair, CEO, and Ben Adams, CFO. Dr. Rich Feifer, Chief Medical Officer, will also be joining the Q&A portion of this call.

Today, after the market close, we issued an earnings press release containing detailed information on our fiscal first quarter results. You may access the release on the Investor Relations section of our company website, innovage.com.

For those listening to the rebroadcast of this call, we remind you that the remarks made herein are as of today, Tuesday, November 5, 2024, and have not been updated subsequent to this call.

During our call, we will refer to certain non-GAAP measures. A reconciliation of these measures to the most directly comparable GAAP measures can be found in our earnings press release posted on our website.

We will also be making forward-looking statements, including statements related to our 2025 fiscal year projections, future growth prospects, and growth strategy, our clinical and operational initiatives, Medicare rate increases, executive leadership transition, the status of current and future regulatory actions, and other expectations. Listeners are cautioned that all of our forward-looking statements involve certain assumptions and are inherently subject to risks and uncertainties that can cause our actual results to differ materially from our current expectations.

We advise listeners to review the risk factors discussed in our Form 10-K annual report for fiscal year 2024 and any subsequent reports filed with the SEC, including our most recent quarterly report on Form 10-Q. After the completion of our prepared remarks, we will open the call for questions.